Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME.
Saved in:
| Title: | Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME. |
|---|---|
| Authors: | de Freitas, Juliano Tiburcio1 (AUTHOR), Thakur, Varsha1 (AUTHOR), LaPorte, Kathryn M.2 (AUTHOR), Thakur, Vijay S.3 (AUTHOR), Flores, Brian1 (AUTHOR), Caicedo, Valentina1 (AUTHOR), Ajaegbu, Chioma G. E.1 (AUTHOR), Ingrasci, Giuseppe1 (AUTHOR), Lipman, Zoe M.1 (AUTHOR), Zhang, Keman4 (AUTHOR), Qiu, Hong4 (AUTHOR), Malek, Thomas R.2 (AUTHOR), Bedogni, Barbara1 (AUTHOR) bxb602@miami.edu |
| Source: | Journal of Experimental & Clinical Cancer Research (17569966). 11/4/2024, Vol. 43 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
